Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (6): 543-544.DOI: 10.3969/j.issn.1673-8640.2019.06.014
• Orginal Article • Previous Articles Next Articles
Received:2018-06-18
Online:2019-06-30
Published:2019-07-04
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.06.014
| [1] | 罗俭权,龙振洪,江灿花,等. 血红蛋白电泳在地中海贫血筛查中的应用价值[J]. 临床和实验医学杂志,2012,11(22):1789. |
| [2] | VIPRAKASIT V,EKWATTANAKIT S.Clinical classification,screening and diagnosis for thalassemia[J]. Hematol Oncol Clin North Am,2018,32(2):193-211. |
| [3] | CHEN J,PENG L,HAN Y,et al.A rapid quantification method for the screening indicator for β-thalassemia with near-infrared spectroscopy[J]. Spectrochim Acta A Mol Biomol Spectrosc,2018,193:499-506. |
| [4] | 王泓,李磊,王霞,等. SEBIA-HYDRASYS电泳系统在血红蛋白电泳检测中应用评价[J]. 现代临床医学,2008,34(3):183-184. |
| [5] | 朱忠勇,庄义,武建国,等. 实用医学检验学[M]. 北京:人民卫生出版社,1992:87-105. |
| [6] | 阮丽明,周艳洁,丁进龙,等. 全自动毛细管电泳仪在血红蛋白分析中的应用[J]. 海南医学,2012,23(1):15-17. |
| [7] | 邓国明. 毛细管电泳在地中海贫血筛查中的应用[J]. 华夏医学,2013,26(6):1121-1124. |
| [8] | 索明环,温冬梅,张秀明,等. 全自动毛细管电泳检测11 519例血红蛋白的结果分析[J]. 检验医学与临床,2013,10(8):913-914. |
| [9] | 韦振空. 全自动血红蛋白电泳在地中海贫血筛查中的应用价值[J]. 医药前沿,2013,3(8):280-281. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
